推荐产品
化驗
≥98% (TLC)
形狀
solid
顏色
white to slightly yellow
溶解度
ethanol: soluble
methanol: soluble
起源
Merck & Co., Inc., Kenilworth, NJ, U.S.
SMILES 字串
Cl.CN1CCC(\CC1)=C2/c3ccccc3C=Cc4ccccc24
InChI
1S/2C21H21N.2ClH.3H2O/c2*1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21;;;;;/h2*2-11H,12-15H2,1H3;2*1H;3*1H2
InChI 密鑰
ZEAUHIZSRUAMQG-UHFFFAOYSA-N
基因資訊
human ... HRH1(3269) , HTR2A(3356) , HTR2B(3357) , HTR2C(3358)
正在寻找类似产品? 访问 产品对比指南
應用
盐酸赛庚啶倍半水合物已被用于:
降钙素基因相关肽(CGRP)的抑制
- 检测5-羟色胺受体(5-HT)诱导的炎症中的抗炎活性
- 螃蟹中体内和体外生物检测中5-HT的抑制
- 胚胎生理性实验中5-HT的抑制
降钙素基因相关肽(CGRP)的抑制
生化/生理作用
赛庚啶盐酸盐倍半水合物是一种血清素受体(5-HT2 / 5-HT1C)拮抗剂、H1组胺受体拮抗剂和止痒剂。赛庚啶对5-HT的抑制作用可改善精神分裂症的认知功能。赛庚啶对治疗功能性胃肠道疾病(FGID)有效。食品药品监督管理局(FDA)批准的赛庚啶具有抗抑郁和抗血小板功能。它可有效地治疗血栓栓塞性疾病。赛庚啶能够抑制赖氨酸甲基转移酶7/9(Set7/9),导致乳腺癌细胞中雌激素受体(ERα)的表达减少和生长停滞。
特點和優勢
该化合物是由Merck & Co., Inc., Kenilworth, NJ, U.S.开发的。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单, 请单击此处。
訊號詞
Danger
危險分類
Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
標靶器官
Respiratory system
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類(WGK)
WGK 3
個人防護裝備
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models
European Journal of Pharmacology, 506(3), 257-264 (2005)
Immunological investigations, 27(6), 379-393 (1998-12-09)
For the immunopharmacological characterization of murine passive anaphylactic shock, the effects of antihistaminics and/or anti-platelet-activating factor (anti-PAF) agents were studied on the shock mediated by allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum. IgE antibody-mediated shock was strongly suppressed
The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function
PLoS ONE, 9(1), e87026-e87026 (2014)
Anti-inflammatory activity of bartogenic acid containing fraction of fruits of Barringtonia racemosa Roxb. in acute and chronic animal models of inflammation
Journal of traditional and complementary medicine, 7(1), 86-93 (2017)
The Journal of pharmacy and pharmacology, 51(8), 953-957 (1999-09-30)
We have previously shown that elimination of buffer Ca2+ markedly reduced maximum 5-HT-induced contractions. We have now investigated the effect of L-type Ca2+-channel blockers and 5-HT2 receptor antagonists on 5-HT- and K+-induced contractions in rat aorta to explore the possibility
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门